comparemela.com

Latest Breaking News On - Urologic cancer - Page 1 : comparemela.com

Adding Olaparib to Abiraterone Does Not Worsen HRQoL in mCRPC

Adding Olaparib to Abiraterone Does Not Worsen HRQoL in mCRPC

Investigators studied health-related quality of life (HRQoL) and pain outcomes for patients with metastatic prostate cancer (mCRPC) taking olaparib plus abiraterone.

Funderburk Joins NAMC

FLORENCE – North Alabama Medical Center recently welcomed Michael Funderburk, MD, to the medical staff as our newest urologist. Dr. Funderburk comes to NAMC from Advanced Urology in Decatur, Georgia.

Patients and Doctors Agree on Treatment Goals Only Half the Time, According to JNCCN Study on People with Neuroendocrine Tumors

Researchers from City of Hope find only 30% of people with neuroendocrine tumors consider living longer to be their single top priority; 70% said addressing and overcoming pain, fatigue, or lack-of-function was more important than just prolonging life. JNCCN announces five new Associate Editors from Duke Cancer Institute, City of Hope, Mayo Clinic Cancer Center, University of Michigan.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.